Ribi ImmunoChem, SmithKline Beecham Pharma GmbH deal

SB Pharma received a license to use RIBI adjuvants commercially upon approval of SB Pharma's allergy vaccines. The license is exclusive for the European Community, Eastern Europe and Canada, and co-ex...